Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention

Autor: Ehtisham Mahmud, Brian P. O'Neill, Navin K. Kapur, William W. O'Neill, Alexandra J. Lansky, E. Magnus Ohman, Jeffrey W. Moses, Theodore Schreiber, Cindy L. Grines, Amin M. Medjamia, Salvatore F. Mannino, J.J. Popma
Rok vydání: 2021
Předmět:
Zdroj: Catheterization and Cardiovascular Interventions.
ISSN: 1522-726X
1522-1946
DOI: 10.1002/ccd.29758
Popis: OBJECTIVES To compare in-hospital outcomes of bailout support to prophylactic support with percutaneous ventricular assist devices (pVAD) for high-risk nonemergent percutaneous coronary intervention (HRPCI). BACKGROUND Prophylactic support with pVAD for a HRPCI is used in patients felt to be at risk for hemodynamic collapse during PCI. An alternative strategy of bailout pVAD support in the event of hemodynamic collapse is also entertained. METHODS We compared the outcomes of patients entered in the cVAD database who underwent Impella Protected PCI (ProPCI group) with patients from the cVAD and USpella databases receiving bailout Impella support for hemodynamic collapse during HRPCI (Bailout group). RESULTS A total of 1,028 patients supported with Impella pVAD were entered into the cVAD database as of July 2019 and were included in this analysis. Of those 971 were in the ProPCI group and 57 in the Bailout group. Patients in the Bailout group were more often female (50.9%vs. 27.2%, p = .0002) with higher median baseline left ventricular ejection fraction (LVEF) (40%vs. 30%, p
Databáze: OpenAIRE